Wednesday , October 20 2021

Resistant bacteria cost a lot of lives and money, warning OECD



[ad_1]

Anti-resistant antibiotic bacteria not only give lives at risk but also weigh on health systems: they could generates up to $ 3.5 billion in annual spending by 2050 in each OECD country, according to a report published on Wednesday, November 7.

"These bacteria are more expensive than flu, AIDS, TB, and they will cost even more if the states are not operating to solve this problem," says public health specialist in AFP, Michele Cechini, at AFP. OECD (Organization for Economic Co-operation and Development).

According to him, Countries already spend an average of 10% of their health budget on treating antibiotic resistant bacteria.

According to projections in the report, which relate to 33 of the 36 OECD countries, bacteria could potentially kill 2.4 million people in Europe, North America and Australia by 2050.

A separate study, published on Monday in The Infectious Diseases of The Lancet, was reported The number of deaths attributable to these bacteria is 33,000 in 2015 in the European Union.

However, we could fight with "simple measures" at moderate cost, according to the OECD: "to encourage better hygiene" (by encouraging, for example, washing hands), "ending over-prescription of antibiotics" or further exhausting the diagnostic tests Quick to determine if infection is viral (in that case the antibiotics are useless) or bacterial.

According to the OECD, these measures would cost only $ 2 per person per year prevent three quarters of deaths.

"Investments could be eliminated in a large public health program that includes some of these measures in a year and would bring savings of $ 4.8 billion a year," says the OECD.

Health authorities, who start with the World Health Organization (WHO), warn regularly risk of antibiotics, which can resist incredible bacteria. Young children and elderly people are particularly at risk.

"In Brazil, Indonesia and Russia, between 40 and 60% of infections already resist, o 'compared to an average of 17% in OECD countries, "said last.

Even more anxiety, "resisting re-or third line antibiotics is expected to be 70% higher in 2030 than in 2005". These antibiotics are those that should be used as a last resort, when there is no other solution.

(With AFP)

[ad_2]
Source link